Clinical pharmacologic observations on 6‐mercaptopurine and 6‐methylthiopurine ribonucleoside
- 1 March 1968
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 9 (2) , 180-194
- https://doi.org/10.1002/cpt196892180
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- On the mode of action of 7-deaza-adenosine (tubercidin)Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1967
- Isolation and antileukemic activity, in mice, of 1-β-d-arabinofuranosylcytosine 5′-phosphate present in synthetic 5′-cytidylic acidBiochemical Pharmacology, 1966
- THE ENZYMIC FORMATION OF 6-(METHYLMERCAPTO)PURINE RIBONUCLEOSIDE 5′-PHOSPHATECanadian Journal of Biochemistry, 1966
- PURINE RIBONUCLEOSIDE KINASE ACTIVITY AND RESISTANCE TO SOME ANALOGS OF ADENOSINE1966
- Protein Solutions: Concentration by a Rapid MethodScience, 1965
- RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES1963
- BIOCHEMICAL ASPECTS OF MERCAPTOPURINE INHIBITION AND RESISTANCE1963
- Clinical Evaluation of a New Antimetabolite, 6-Mercaptopurine, in the Treatment of Leukemia and Allied DiseasesBlood, 1953